The Annual General Meeting of Orion Corporation was held on Wednesday 23 March 2022. The decisions and related material are available here.
Orion published Interim Report 1-3/2022 on Thursday, 28 April 2022. The report and related presentation material and a link to webcast is available here.
Orion Group's Financial Statement documents for 2020 are available here.
The product and service portfolio of Orion includes a variety of human pharmaceuticals, veterinary drugs, APIs and contract manufacturing.
Orion is the largest employer in the Finnish pharmaceutical industry. It is considered to be a good and reliable employer, which is also indicated by its lower-than-average employee turnover.
From the sustainability section you will find, among others, our Sustainability reports, Code of Conduct and Quality Policy.
